Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan G Walker

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2008
Erythropoietin stimulating agents and epoetin alfa revisited: what's really relevant?Rowan G Walker
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2012
Fostering the ability of patients to self-manage their CKDRowan G Walker, Rachelle Buchbinder
Seminars in Dialysis|February 7, 2008
The role of medical directors in dialysis facilitiesJudy Lowthian, Rowan G Walker
The Medical Journal of Australia|July 25, 2013
International treatment guidelines for anaemia in chronic kidney disease - what has changed?Robert J Macginley, Rowan G Walker
Lancet (London, England)|October 24, 2007
A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogateRowan G Walker, Giovanni F M Strippoli
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2004
Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysisLawrence P McMahon, Kate Chester, Rowan G Walker
Clinical Transplantation|January 15, 2008
The improvement in survival of expanded criteria donor kidneys with transplantation eraRobert P Carroll, Lachlan Macgregor, Rowan G Walker
Current Medical Research and Opinion|October 22, 2009
Haemoglobin fluctuations in patients on haemodialysis treated with ESAs: clinical observations from two centresAlison Roche, Iain C Macdougall, Rowan G Walker
BMC Family Practice|January 13, 2010
The devil is in the detail - a multifactorial intervention to reduce blood pressure in co-existing diabetes and chronic kidney disease: a single blind, randomized controlled trialAllison F Williams, Elizabeth Manias, Rowan G Walker
Nephrology (Carlton, Vic.)|October 31, 2012
Trade-off between the benefits of lithium treatment and the risk of chronic kidney diseaseWilliam R Adam, Isaac Schweitzer, Isaac Sshweitzer, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2008
Erythropoietin stimulating agents and epoetin alfa revisited: what's really relevant?Rowan G Walker
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2012
Fostering the ability of patients to self-manage their CKDRowan G Walker, Rachelle Buchbinder
Seminars in Dialysis|February 7, 2008
The role of medical directors in dialysis facilitiesJudy Lowthian, Rowan G Walker
The Medical Journal of Australia|July 25, 2013
International treatment guidelines for anaemia in chronic kidney disease - what has changed?Robert J Macginley, Rowan G Walker
Lancet (London, England)|October 24, 2007
A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogateRowan G Walker, Giovanni F M Strippoli
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2004
Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysisLawrence P McMahon, Kate Chester, Rowan G Walker
Clinical Transplantation|January 15, 2008
The improvement in survival of expanded criteria donor kidneys with transplantation eraRobert P Carroll, Lachlan Macgregor, Rowan G Walker
Current Medical Research and Opinion|October 22, 2009
Haemoglobin fluctuations in patients on haemodialysis treated with ESAs: clinical observations from two centresAlison Roche, Iain C Macdougall, Rowan G Walker
BMC Family Practice|January 13, 2010
The devil is in the detail - a multifactorial intervention to reduce blood pressure in co-existing diabetes and chronic kidney disease: a single blind, randomized controlled trialAllison F Williams, Elizabeth Manias, Rowan G Walker
Nephrology (Carlton, Vic.)|October 31, 2012
Trade-off between the benefits of lithium treatment and the risk of chronic kidney diseaseWilliam R Adam, Isaac Schweitzer, Isaac Sshweitzer, et al.
Pageof 7